Open Access to CPDD Late-breaking Abstracts

Hello Colleagues,

The College on the Problems of Drug Dependence (CPDD) has composed an array of late-breaking talks - ranging from xylazine exposure to ED-delivered buprenorphine to international efforts in tobacco intervention. These talks are open access and available for you NOW at the following link: https://www.youtube.com/watch?v=qg2kLFYpscc  The list of talks and speakers is provided for you below.

This is a sample of the digital programming that has been made available by CPDD this year- more information about registering and digital program offerings is available here: https://cpdd.org/meetings/current-meeting/cpdd-digital-experience/

• 0:00 Recent Xylazine Exposure Among Opioid Overdose Decedents, Renee Johnson, PhD, Johns Hopkins Bloomberg School of Public Health
• 5:25 Risks and Benefits of Obtaining a Medical Marijuana Card in Adults With Pain, Insomnia, or Affective Symptoms: A Randomized Clinical Trial, Jodi Gilman, PhD, Massachusetts General Hospital-Psychiatry
• 13:54: Trust in Provider Mediates the Relationship Between Shared Decision Making and Opioid Misuse in a Nationally Representative Sample of U.S. Veterans Prescribed Long-Term Opioid Therapy for Chronic Pain, Vanessa Somohano, PhD, VA Portland Health Care System
• 18:44: Implementation of Emergency Department-Initiated Buprenorphine for Opioid Use Disorder, Gail D'Onofrio, MD, Yale University School of Medicine
• 26:06: Contingency Management for Smoking Cessation Among Smokers With Overweight or Obesity, Gloria García-Fernández, PhD, University of Oviedo, Spain
• 30:27 An Examination of the Relationship Between Adverse Childhood Experiences (ACEs) and Substance Use Disorders (SUDs) Utilizing an Intersectionality Framework, Delisa Brown, PhD, Medical University of South Carolina Dept of Psychiatry & Behavioral Sciences
• 35:51: Absence of Withdrawal Symptoms upon Discontinuation of Daily Kratom Use in Three Formulations in a Controlled Clinical Study, Marilyn Huestis, PhD, National Institute of Drug Abuse, National Institutes of Health
• 40:30: Methamphetamine-Related Overdoses Before and During the COVID-19 Pandemic, Andrew Mike, MS, University of Florida
• 45:30: Differences Between Legal and Illegal Cannabis Demand in Spanish Young Adults With Hazardous and Non-Hazardous Cannabis Use, Alba Gonzalez-Roz, PhD, Department of Psychology - University of Oviedo
• 51:46: “My Dad Brought Me to a Drug Joint”: A Qualitative Study on Adolescents and Amphetamine; Factors of Initiation, Amirul Danial Azmi, MD, Universiti Kebangsaan Malaysia Medical Centre
• 56:06: Contingency Management for Cigarette Smoking Cessation in Young People With Borderline Personality Disorder Features, Gillinder Bedi, BA, BSc, The University of Melbourne